Clinical Trial Update: Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta® [Phase 3]

View source ↗

Summary

Phase III study comparing LA-EP2006 to Neulasta in preventing chemotherapy-induced neutropenia in breast cancer; the trial was completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Neutropenia

Drugs mentioned

• LA-EP2006 (pegfilgrastim)
• NEULASTA (pegfilgrastim)

Snippet

Sponsor: Sandoz | Conditions: Neutropenic Complications, Breast Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2017-06-15